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PAcute Coronary Syndromes
ardiac Troponin T at 96 Hours
fter Acute Myocardial Infarction
orrelates With Infarct Size and Cardiac Function
enning Steen, MD,* Evangelos Giannitsis, MD, FESC, MD,* Simon Futterer,* Constanze Merten, MD,*
laus Juenger, MD,† Hugo A. Katus, MD, FESC*
eidelberg and Ludwigshafen, Germany
OBJECTIVES In clinical practice, myocardial infarct size can be estimated non-invasively by nuclear imaging
techniques or contrast-enhanced magnetic resonance imaging (CE-MRI). Due to limited
availability and high costs, serologic tests are frequently used as an alternative.
BACKGROUND We examined the ability of a single value of cardiac troponin T (cTnT) 96 h after onset of
ST-/non–ST-segment elevation myocardial infarction (STEMI/NSTEMI) to estimate
absolute infarct mass.
METHODS Functional and CE-MRI were conducted on a 1.5-T whole-body system 4 days after
STEMI/NSTEMI using gadolinium (0.2 mmol/kg/bw). Infarct sizes were measured
employing a specified software (Philips Medical Systems, Best, the Netherlands) and
correlated with TnT measurements 96 h after onset of STEMI/NSTEMI.
RESULTS We enrolled 23 STEMI and 21 NSTEMI patients. Median time delay from onset of
symptoms to balloon angioplasty was 6.25 and 9.9 h for STEMI/NSTEMI patients,
respectively. Contrast-enhanced magnetic resonance imaging (median 4 days) revealed an
absolute mean infarct size of 16.2 g (7.7 to 30.1 g) with a mean ejection fraction of 58% (53%
to 63%) and mean stroke volume of 84 ml (75 to 107 ml). Absolute infarct sizes and median
cTnT values were larger in STEMI than in NSTEMI (29.3 g [interquartile range (IQR) 16.0
to 53.0] and 1.88 g/l [IQR 0.7 to 2.57] vs. 8.8 g [IQR 3.3 to 16.4] and 0.83 g/l [IQR 0.4
to 1.3], both p  0.02). Linear regression analysis was excellent for STEMI (r  0.910) and
moderate albeit still significant for NSTEMI (r  0.575).
CONCLUSIONS A single 96-h cTnT value provides an accurate estimate of absolute infarct mass in myocardial
infarction. The ability to quantify and the potential to distinguish effects of novel drug
regimens on infarct size make cTnT attractive for routine practice and as a clinical end
point. (J Am Coll Cardiol 2006;48:2192–4) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.06.002Cardiology Foundation
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n routine clinical practice, infarct size is estimated non-
nvasively by electrocardiographic and imaging techniques
ncluding radionuclide imaging, technetium-99m sestamibi,
r thallium scintigraphy (1). Due to the limited availability
nd high costs, serologic tests are frequently used as an
lternative. The frequently used serum concentrations of
ytoplasmatic enzymes such as creatine kinase (CK) or
K-MB and lactate (LDH) or hydroxybutyrate dehydro-
enase (HBDH) for estimation of infarct size is hampered
y the need for serial measurements to identify peak or
umulative serum concentrations. A second shortcoming is
he lack of cardiospecificity. Cardiac enzymes and, to a
esser degree, CK-MB mass are also expressed in skeletal
uscle cells. Thus, the origin of elevated markers cannot be
nequivocally allocated in many cases (2). In contrast,
ardiac troponin T (cTnT) is a structural protein of the
yofilament, which is exclusively expressed in cardiomyo-
From the *Abteilung Innere Medizin III, Medizinische Klinik, Universitätsklini-
um Heidelberg, Heidelberg, Germany; and the †Herzzentrum Ludwigshafen,
nstitut für Biometrie, Ludwigshafen, Germany. Dr. Steen and Dr. Giannitsis
ontributed equally to this work.i
Manuscript received January 3, 2006; revised manuscript received July 19, 2006,
ccepted July 23, 2006.ytes. Upon irreversible injury, cTnT serum concentrations
how a biphasic curve with an early peak within 24 h
esulting from the release of a small cytoplasmatic pool and
“plateau phase” 72 to 96 h after the onset of symptoms
esulting from continuous proteolytic degradation of the
ontractile apparatus (3,4).
We hypothesized that a single cTnT measurement at
6 h could represent an ideal estimate for infarct size. To
est this hypothesis, we quantified infarct size and left
entricular function by contrast-enhanced cardiac magnetic
esonance imaging (CE-MRI).
ETHODS
uring July 2004 to March 2005, we enrolled 44 patients
dmitted to the chest pain unit of the University of
eidelberg with an acute myocardial infarction. Myocardial
nfarction was diagnosed in accordance with European
ociety of Cardiology/American Heart Association Guide-
ines. Acute myocardial infarction without ST-segment
levation was defined by an elevation of cTnT above 0.03
g/l on at least 1 occasion within 24 h after the ischemicndex event with a rise or fall during subsequent sampling.
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December 5, 2006:2192–4 96-h TnT Post-AMI Correlates Best With Infarct Sizecute ST-segment elevation myocardial infarction (STEMI)
as defined by elevation of the ST-segment 0.1 mV in at
east 2 contiguous leads or new onset of left bundle branch.
n all patients, acute myocardial infarction was retrospec-
ively confirmed by an elevation of cTnT above 0.03 g/l.
lood samples were taken on admission and 96 h after onset
f ischemic symptoms were centrifuged and stored at
20°C until assayed. The study protocol complies with the
eclaration of Helsinki, was approved by the local institu-
ional ethical committee, and patients gave written in-
ormed consent.
easurement of cTnT. Blood samples were taken on
dmission and 96 h after onset of ischemic symptoms.
ardiac troponin T was measured quantitatively using
lectrochemiluminescence technology (3rd generation
TnT, Elecsys 2010, Roche, Mannheim, Germany). The
ower detection limit of this assay is 0.01 g/l with a
ecommended diagnostic threshold of 0.03 g/l.
ardiac MRI. Cardiac MRI was performed in a 1.5-T
hole-body MRI scanner (Philips Medical Systems, Best,
he Netherlands). Assessment of resting left ventricular
unction was determined by cine images using a steady-state
ree precession sequence in continuous short-axis planes
overing the whole left ventricle from base to apex as well as 2-
nd 4-chamber views. Ten minutes after gadolinium contrast
njection (Gd  0.2 mmol/kg body weight of gadopentetate
imeglumine [Schering, Berlin, Germany]), 3 volume stacks of
elayed contrast-enhanced images covering the whole left
entricle were planned on previous short-, 2-, and
-chamber axis.
End-diastolic and -systolic volumes with resulting ejec-
ion fraction were generated manually using short-axis
olumetry. Infarct size was visually defined as area of
elayed hyperenhancement on short-axis views and deter-
ined manually by delineation of hyperenhanced versus
ormally saturated dark myocardium.
Magnetic resonance imaging analysis included quantifi-
ation of absolute infarct size (grams) and left ventricular
unction in all patients.
tatistics. Plasma concentrations of cTnT are described as
edian values with the corresponding interquartile range
IQR). The baseline characteristics of patients with STEMI
Abbreviations and Acronyms
CE-MRI  contrast-enhanced cardiac magnetic
resonance imaging
CK  creatine kinase
cTnT  cardiac troponin T
HBDH  hydroxybutyrate dehydrogenase
IQR  interquartile range
LDH  lactate
MRI  magnetic resonance imaging
NSTEMI  non–ST-segment elevation myocardial
infarction
STEMI  ST-segment elevation myocardial infarctionnd non–ST-segment elevation myocardial infarction tNSTEMI) were compared using the Student t test or
hi-square test. For all analyses, a value of p  0.05 was
egarded as statistically significant.
ESULTS
e included 44 patients with a mean age of 58  12 years.
total of 28% of patients were women; mean body mass
ndex was 28  4 kg/m2 (arterial hypertension  57%,
urrent smoking  50%, elevated cholesterol levels  57%,
iabetes  16%). Twenty-three patients had STEMI and
1 had NSTEMI. Another 5 patients had received glyco-
rotein inhibitors before angiography. Pre-interventional
hrombolysis In Myocardial Infarction (TIMI) flow grade
was present in 12 of 23 patients (52.2%) with STEMI and
of 21 patients (38.1%) with NSTEMI. Primary percuta-
eous coronary intervention was successfully attempted in
2 of 23 patients with STEMI, and early percutaneous
oronary intervention was attempted in 20 of 21 patients
ith NSTEMI. For STEMI, the median time delay from
nset of symptoms to balloon angioplasty was 6.25 h and
.9 h for NSTEMI.
Magnetic resonance imaging was performed after a me-
ian of 4 days. Mean infarct size was 16.2 g (7.7 to 30.1 g).
he left ventricular performance revealed a mean ejection
raction of 58% (53% to 63%) with a mean stroke volume of
4 ml (75 to 107 ml).
Absolute infarct sizes were larger in STEMI than in
STEMI (29.3 g [IQR 16.0 to 53.0] vs. 8.8 g [IQR 3.3 to
6.4], p  0.0002). Correspondingly, median cTnT values
ere higher in STEMI than in NSTEMI (1.88 g/l [IQR
.7 to 2.57] vs. 0.83 g/l [IQR 0.4 to 1.3], p  0.015).
Linear regression analysis showed a strong significant
orrelation between cTnT and infarct size (Figs. 1A and
B). Correlation between cTnT and infarct size was excel-
ent for STEMI (Fig. 1A) and moderate, albeit still signif-
cant, for NSTEMI (Fig. 1B).
ISCUSSION
n the present study, we tested the hypothesis whether a
ingle cTnT sample obtained 96 h after the onset of
ymptoms correlates with infarct size as determined by
E-MRI. Our study provides 2 novel findings. First, a single
TnT at 96 h correlates strongly with absolute MRI infarct
ize. This relationship is highly significant in STEMI, and less
mpressive, albeit significant, in NSTEMI. Second, sampling
t 96 h may not be the optimal time point for single
easurement due to heterogenous time release curves of
TnT in NSTEMI.
Infarct size is a valuable surrogate outcome measure for
linical trials in patients with acute coronary syndromes and
an either be measured non-invasively by employing elec-
rocardiographic criteria or by using more advanced, but less
vailable, radionuclide techniques (1). As an alternative and
ue to limited availability and high costs of imaging
echniques, serologic tests are frequently utilized measuring
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K-MB, LDH, or HBDH. Unfortunately, there are 2 major
hortcomings with these markers. First, the lack of cardiospeci-
city sometimes allows more sources to be responsible for the
ise of these markers (2). Second, measurement of infarct size
y cardiac enzymes is hampered by the need to collect blood
epeatedly so as not to miss the peak of marker release. In
ontrast, cTnT is an exclusively cardiac and predominantly
tructural protein of the myofilament.
Cardiac MRI has become the gold standard for quanti-
cation of ventricular function and determination of infarct
ize (1). Constrast-enhanced MRI has been shown to allow
uantification of spontaneous or post-procedural MI of 1 g
f infarcted myocardium per image (5) and has a better
ensitivity for detection of small myocardial infarcts than
ingle photon emission tomography (6). These and other
dvantages including the ability to detect infarct-related
omplications such as microvascular obstruction, papillary
uscle necrosis, or extension of infarct to the right ventricle
utweigh the potential shortcoming of overestimating in-
arct size by approximately 10% during the acute phase (7).
Generally, infarct sizes for NSTEMI patients were sig-
ificantly smaller and could, in some cases, be below the
RI detection threshold for myocardial infarcts. Moreover,
ue to relatively low image resolution of CE-MRI images,
mall infarct areas could also be missed due to partial
olume effect. Furthermore, in our approach, we performed
car imaging 10 min after administration of gadolinium.
his could be either too early for clear visualization of small
nfarcts, or small infarcts potentially have different contrast
gent wash-in and wash-out kinetics when compared with
arger infarcts with edema and more pronounced microvas-
igure 1. Regression correlation between single cardiac troponin T (TnT
nfarction (STEMI) (A) and non–ST-segment elevation myocardial infarcular obstruction.However, it is tempting to speculate that patients with
mall infarcts have different cTnT release time curves than
atients with large myocardial infarction. Therefore, it
annot be excluded that, in patients with NSTEMI, an
arlier cTnT sampling time point would have resulted in a
etter correlation with infarct size or left ventricular function.
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